Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
INTRODUCTION: Peroxisome proliferator-activated receptors (PPARs) are the molecular targets of hypolipidemic and insulin-sensitizing drugs and implicated in a multitude of processes that fine-tune the functions of all organs in vertebrates. As transcription factors they sense endogenous and exogenou...
Saved in:
Main Authors: | Tan, Chek Kun, Zhuang, Yan, Wahli, Walter |
---|---|
其他作者: | Lee Kong Chian School of Medicine (LKCMedicine) |
格式: | Article |
語言: | English |
出版: |
2017
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/83609 http://hdl.handle.net/10220/42711 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
由: Fougerat, Anne, et al.
出版: (2020) -
Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology
由: Manickam, Ravikumar, et al.
出版: (2017) -
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
由: Tan, Nguan Soon, et al.
出版: (2017) -
An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors
由: Liao, Zehuan, et al.
出版: (2018) -
Single gene contributions: Genetic variants of peroxisome proliferator-activated receptor (isoforms α, β/δ and γ) and mechanisms of dyslipidemias
由: Yong, E.L., et al.
出版: (2011)